BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 23542145)

  • 1. Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals.
    Lin TY; Lu CW; Huang SK; Wang SJ
    J Ethnopharmacol; 2013 May; 147(2):488-96. PubMed ID: 23542145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTDP-2, a new synthetic compound, inhibits glutamate release through reduction of voltage-dependent Ca²⁺ influx in rat cerebral cortex nerve terminals.
    Lin TY; Lu CW; Huang SK; Chou SS; Kuo YC; Chou SH; Tzeng WF; Leu CY; Huang RF; Liew YF; Wang SJ
    Pharmacology; 2011; 88(1-2):26-32. PubMed ID: 21720189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hispidulin inhibits the release of glutamate in rat cerebrocortical nerve terminals.
    Lin TY; Lu CW; Wang CC; Lu JF; Wang SJ
    Toxicol Appl Pharmacol; 2012 Sep; 263(2):233-43. PubMed ID: 22759588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan.
    Lin TY; Lu CW; Wang SJ
    Neurochem Int; 2009 Jul; 54(8):526-34. PubMed ID: 19428798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDT-1, a new synthetic compound, inhibits glutamate release in rat cerebral cortex nerve terminals (synaptosomes).
    Wang SJ; Chou SH; Kuo YC; Chou SS; Tzeng WF; Leu JY; Huang RF; Liew YF
    Acta Pharmacol Sin; 2008 Nov; 29(11):1289-95. PubMed ID: 18954522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidine.
    Chiu KM; Lin TY; Lu CW; Wang SJ
    Eur J Pharmacol; 2011 Nov; 670(1):137-47. PubMed ID: 21914443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimebon, an antihistamine drug, inhibits glutamate release in rat cerebrocortical nerve terminals.
    Wang CC; Kuo JR; Wang SJ
    Eur J Pharmacol; 2014 Jul; 734():67-76. PubMed ID: 24726847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase Cα in rat cerebral cortex nerve terminals.
    Kuo JR; Wang CC; Huang SK; Wang SJ
    Neurochem Int; 2012 Jan; 60(2):105-14. PubMed ID: 22142530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyanocobalamin, vitamin B12, depresses glutamate release through inhibition of voltage-dependent Ca2+ influx in rat cerebrocortical nerve terminals (synaptosomes).
    Hung KL; Wang CC; Huang CY; Wang SJ
    Eur J Pharmacol; 2009 Jan; 602(2-3):230-7. PubMed ID: 19073169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. σ-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings.
    Lu CW; Lin TY; Wang CC; Wang SJ
    J Pharmacol Exp Ther; 2012 May; 341(2):532-42. PubMed ID: 22357973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fangchinoline inhibits glutamate release from rat cerebral cortex nerve terminals (synaptosomes).
    Lin TY; Lu CW; Tien LT; Chuang SH; Wang YR; Chang WH; Wang SJ
    Neurochem Int; 2009 Jul; 54(8):506-12. PubMed ID: 19428795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca(2+) entry and mitogen-activated protein kinase signaling pathway.
    Lin TY; Lu CW; Wang SJ
    J Agric Food Chem; 2010 Jul; 58(14):8271-8. PubMed ID: 20593829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
    Wang SJ
    Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals.
    Lin TY; Yang TT; Lu CW; Wang SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):598-606. PubMed ID: 21216268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex.
    Lu CW; Lin TY; Wang SJ
    Neurotoxicology; 2013 Dec; 39():1-9. PubMed ID: 23933436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible neuroprotective mechanism?
    Yang TT; Wang SJ
    J Pharmacol Exp Ther; 2009 Oct; 331(1):244-54. PubMed ID: 19628631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism.
    Lin TY; Lu CW; Wang CC; Wang YC; Wang SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1785-93. PubMed ID: 21741425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myricetin inhibits the release of glutamate in rat cerebrocortical nerve terminals.
    Chang Y; Chang CY; Wang SJ; Huang SK
    J Med Food; 2015 May; 18(5):516-23. PubMed ID: 25340625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings.
    Lin TY; Lu CW; Wang CC; Huang SK; Wang SJ
    J Pharmacol Exp Ther; 2014 Oct; 351(1):134-45. PubMed ID: 25047516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q10 inhibits the release of glutamate in rat cerebrocortical nerve terminals by suppression of voltage-dependent calcium influx and mitogen-activated protein kinase signaling pathway.
    Chang Y; Huang SK; Wang SJ
    J Agric Food Chem; 2012 Dec; 60(48):11909-18. PubMed ID: 23167655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.